Clinical trial
Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis
NCT01282528 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2010
- Completion date
- Not reported
- Enrollment
- 85 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infliximab, rheumatoid arthritis, ultrasonography